| Financial Year |
March 31 2023 |
| Monetary Funds |
1,085,825,648.79 |
| Held-for-trading Financial Assets |
362,974,772.29 |
| Notes Receivable |
2,046,855.04 |
| Accounts Receivable |
872,111,010.49 |
| Advances to Suppliers |
105,600,577.42 |
| Other Receivables |
69,638,702.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
17,500,771.05 |
| Dividend Receivable |
-- |
| Inventories |
1,318,661,497.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
77,228,055.27 |
| Total Current Assets |
4,450,047,180.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
569,183,760.82 |
| Investment Properties |
516,563,212.85 |
| Fixed Assetes |
56,682,099.28 |
| Under-construction Projects |
288,741.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,405,909.66 |
| R&D expenses |
-- |
| Goodwill |
50,365,036.62 |
| Long-Term Deferred and Prepaid Expenses |
22,754,233.67 |
| Deferred Income Tax Assets |
27,462,331.94 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,977,082,682.23 |
| Total Assets |
6,427,129,862.60 |
| Short-Term Loans |
1,029,590,458.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,714,000.00 |
| Accounts Payable |
510,205,498.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
261,787,804.89 |
| Taxes Payable |
25,921,879.12 |
| Interest Payable |
-- |
| Dividend Payable |
2,820,000.00 |
| Other payables |
54,744,822.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,817,344.41 |
| Other Current Liabilities |
210,241,783.76 |
| Sub-Total of Current Liabilities |
2,572,152,600.05 |
| Long-term Loans |
20,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,433,619.02 |
| Other Non-Current Liabilities |
613,210.41 |
| Sub-Total of Non-Current Liabilities |
43,310,048.33 |
| Total Liabilities |
2,615,462,648.38 |
| Paid-In Capital(Or Share Stock) |
940,815,005.00 |
| Capital Surplus |
1,409,285,610.36 |
| Surplus Reserve |
185,197,062.42 |
| LESS:Treasury Stock |
99,977,357.84 |
| Undistributed Profits |
1,224,430,719.79 |
| Minority Stockholder's Interest |
141,406,444.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,670,260,769.32 |
| Owner's Equity（Stockholder's Equity） |
3,811,667,214.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,427,129,862.60 |
